Compounds > cyclam
Page last updated: 2024-08-24

cyclam and Neoplasms

cyclam has been researched along with Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aboagye, EO; Alam, IS; Barnes, C; Braga, M; Brickute, D; Carroll, L; Kaliszczak, MA; Lau, D; Nguyen, QD; Stevens, E; Trousil, S1
Botting, KJ; Brothers, PJ; Chang, JY; Clark, GR; Denny, WA; Ferry, DM; Lu, GL; Stevenson, RJ; Tercel, M; Ware, DC; Wilson, WR1
Hoffman, TJ; Smith, CJ1
Boturyn, D; Dumy, P; Fujibayashi, Y; Fukumura, T; Furukawa, T; Galibert, M; Jin, ZH; Saga, T1
Delgado, R; Félix, V; Lima, LM; Price, DW1
Archibald, SJ; Greenman, J; Khan, A1

Reviews

1 review(s) available for cyclam and Neoplasms

ArticleYear
Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates.
    Current medicinal chemistry, 2007, Volume: 14, Issue:21

    Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Benzylamines; Chemokine CXCL12; Chemokines; Cyclams; Heterocyclic Compounds; HIV Infections; Humans; Neoplasms; Receptors, CXCR4; Structure-Activity Relationship

2007

Other Studies

5 other study(ies) available for cyclam and Neoplasms

ArticleYear
Development and Evaluation of an
    Molecular pharmaceutics, 2019, 05-06, Volume: 16, Issue:5

    Topics: Animals; Cell Line, Tumor; Chemokine CXCL12; Female; Fluorodeoxyglucose F18; Gene Knockdown Techniques; Heterocyclic Compounds; Heterografts; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasms; Organic Cation Transport Proteins; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Receptors, CXCR4; Renal Elimination; Tissue Distribution

2019
Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs.
    Inorganic chemistry, 2013, Jul-01, Volume: 52, Issue:13

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cobalt; Coordination Complexes; Crystallography, X-Ray; Cyclams; Heterocyclic Compounds; Humans; Ligands; Mice; Models, Molecular; Neoplasms; Prodrugs

2013
True radiotracers: Cu-64 targeting vectors based upon bombesin peptide.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:6

    Topics: Animals; Bombesin; Carboxylic Acids; Copper Radioisotopes; Diagnostic Imaging; Heterocyclic Compounds; Humans; Mice; Neoplasms; Protein Binding; Radioactive Tracers; Radiochemistry; Radiopharmaceuticals; Radiotherapy; Receptors, Bombesin; Tissue Distribution

2009
RGD-cyclam conjugate: synthesis and potential application for positron emission tomography.
    Bioorganic & medicinal chemistry letters, 2010, Sep-15, Volume: 20, Issue:18

    Topics: Animals; Copper Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Mice; Mice, Nude; Neoplasms; Oligopeptides; Positron-Emission Tomography

2010
Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data.
    Dalton transactions (Cambridge, England : 2003), 2007, Jul-14, Issue:26

    Topics: Chelating Agents; Cyclams; Heterocyclic Compounds; Humans; Lanthanoid Series Elements; Molecular Structure; Neoplasms; Organometallic Compounds; Radionuclide Imaging; Radiopharmaceuticals; Thermodynamics; Transition Elements

2007